Blank, C; Ma, J; Grob, JJ; Larkin, J; Neyns, B; McNeil, C; Lotem, M; Richtig, E; Masucci, G; Petrella, T; Ribas, A; Wang, J; Ibrahim, N; Anderson, KM; Arance, A.
Estimating the percentage of patients with advanced melanoma achieving long-term survival with pembrolizumab (Pembro) treatment in KEYNOTE-006
ANN ONCOL. 2016; 27:
Doi: 10.1093/annonc/mdw379.10
Web of Science
FullText
FullText_MUG